Agios Pharmaceuticals | AGIO - 当期純利益





当期純利益 変化する 日付
AbbVie USD 3.61B 2.92B 2026-06
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amgen USD 2.38B 556M 2026-06
Arrowhead Research USD -194.28M 61.55M 2026-06
Astellas Pharma JPY 141.83B 98.31B 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bayer EUR 219M 2.54B 2026-06
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Daiichi Sankyo JPY 68.64B 18B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Exelixis USD 212.05M 1.58M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Incyte USD 585.6M 282.27M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Merck USD -1.34B 2.9B 2026-06
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Novartis USD 3.26B 108M 2026-06
Novartis USD 3.16B 747M 2026-03
Pfizer USD -248M 2.94B 2026-06
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06